← Back to all trials
Completed
NCT06858137
Thread Embedding Acupuncture For Rhinitis Allergy
Conditions: Rhinitis Allergic
Sex: All
Ages: 18 Years – 70 Years
Healthy volunteers: No
Phase: NA
Enrollment: 64
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City
Location: University of Medical Center HCMC - Branch no.3 Ho Chi Minh City
Summary
Rhinitis allergy is chronic non-communicable disease with a rapid increase in the number of patients since 1990s. Rhinitis allergy is one of the risk factors for various chronic others including asthma, sinusitis, otitis media, as well as some conditions sleep disorders, emotional disorders related.
There are numerous pharmacological and non-pharmacological therapies that have been employed in management of these condition. Among them, thread embedding acupuncture (TEA) has been a widely used and established method for various chronic diseases, demonstrating its effectiveness, safety, and convenience. Several studies have shown a significant increase in treatment when combining TEA with pharmacological or other acupuncture therapies. However, there is currently no substantial data on the application of TEA for rhinitis allergy treatment.
This study is conducted to assess the efficacy and safety of combining TEA with inhaled corticosteroid (INCS) compared with ICS monotherapy in rhinitis allergy
Eligibility Criteria
Inclusion Criteria:
* Those not participating in any other clinical trial
* Those who provide written informed consent
* Those with typical symptoms of AR, rhinorrhea, sneezing, nasal obstruction, and pruritus. These symptoms should last at least one hour most day since last two week.
Exclusion Criteria:
* Pregnancy, lactation, or recent childbirth within the past 6 months.
* Those were receiving immune therapy
* Those with other allergic diseases such as bronchial asthma or allergic purpura
* Those with nasal polyposis
* Those with heterologous protein allergy
* Those with other disorders such as AIDS, vascular malformation, hypertension, hematologic, diseases, diabetes mellitus, malignant tumor, or mental disorders.
Source: ClinicalTrials.gov (NCT06858137). StuddyBuddy aggregates publicly available trial information.